Clinical Pharmacology of Citrus bergamia: A Systematic Review

Phytotherapy Research

Volumn 31, Issue 1, 2017, Pages 27-39

  Mannucci, Carmen ^a   Navarra, Michele ^a   Calapai, Fabrizio ^a   Squeri, Raffaele ^a   Gangemi, Sebastiano ^b   Calapai, Gioacchino ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

bergamot; bergamot essential oil; bergamot juice; Citrus bergamia Risso et Poiteau

Indexed keywords

BERGAPTEN; CITRUS BERGAMIA EXTRACT; LIPOPROTEIN; PLACEBO; PLANT EXTRACT; PSORALEN; ROSUVASTATIN; UNCLASSIFIED DRUG; BERGAMOT OIL; VEGETABLE OIL;

ANTIMICROBIAL ACTIVITY; ANXIETY; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CHOLESTEROL METABOLISM; CITRUS; CITRUS BERGAMIA; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; MENTAL STRESS; NERVE CELL PLASTICITY; NONHUMAN; PEER REVIEW; PHOTOAGING; PHOTOPHERESIS; PHOTOTHERAPY; PHOTOTOXICITY; PHYTOCHEMISTRY; POLYMORPHONUCLEAR CELL; PSORIASIS; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT INDICATION; ULTRAVIOLET B RADIATION; WATER VAPOR; WORKLOAD; WORKPLACE; CHEMISTRY;

CITRUS; HUMANS; PLANT OILS;

EID: 84991475852     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5734     Document Type: Review

References (47)

1. Bagetta G, Morrone LA, Rombolà L, et al. 2010. Neuropharmacology of the essential oil of bergamot. Fitoterapia 81: 453–461.
2. Caristi C, Bellocco E, Panzera V, Toscano G, Vadalà R, Leuzzi U. 2003. Flavonoids detection by HPLC-DAD-MS-MS in lemon juices from Sicilian cultivars. J Agric Food Chem 51: 3528–3534.
3. Celia C, Trapasso E, Locatelli M, et al. 2013. Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells. Colloids Surf B Biointerfaces 112: 548–53.
4. Chang KM, Shen CW. 2011. Aromatherapy benefits autonomic nervous system regulation for elementary school faculty in Taiwan. Evid Based Complement Alternat Med Article ID 946537.
5. Choe SC, Kim HS, Jeong TS, Bok SH, Park YB. 2001. Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits. J Cardiovasc Pharmacol 38: 947–955.
6. Cirmi S, Bisignano C, Mandalari G, Navarra M. 2016. Anti-infective potential of Citrus bergamia Risso et Poiteau (bergamot) derivatives: a systematic review. Phytother Res 30 (9): 1404–11.
7. Corasaniti MT, Maiuolo J, Maida S, et al. 2007. Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro. Br J Pharmacol 151(4): 518–29.
8. Costa R, Dugo P, Navarra M, RaymoV DG, Mondello L. 2010. Study on the chemical composition variability of some processed bergamot (Citrus bergamia) essential oils. Flavour Fragr J 25(1): 4–12.
9. Currò M, Risitano R, Ferlazzo N, et al. 2016. Citrus bergamia juice extract attenuates β-amyloid-induced pro-inflammatory activation of THP-1 cells through MAPK and AP-1 pathways. Sci Rep 6: 20809.
10. Delle Monache S, Sanità P, Trapasso E, et al. 2013. Mechanisms underlying the anti-tumoral effects of Citrus bergamia juice. PLoS ONE 8e61484.
11. Di Donna L, De Luca G, Mazzotti F, et al. 2009. Statin-like principles of bergamot fruit (Citrus bergamia): isolation of 3-hydroxymethylglutaryl flavonoid glycosides. J Nat Prod 72: 1352–1354.
12. Ferlazzo N, Cirmi S, Russo M, et al. 2016a. NF-κB mediates the antiproliferative and proapoptotic effects of bergamot juice in HepG2 cells. Life Sci. 146: 81–91.
13. (3+)-induced oxidative stress. Environ Toxicol Pharmacol 43: 248–56.
14. Ferlazzo N, Visalli G, Smeriglio A, et al. 2015. Flavonoid fraction of orange and bergamot juices protect human lung epithelial cells from hydrogen peroxide-induced oxidative stress. Evid Based Complement Alternat Med 2015: 957031.
15. Gagnier JJ, Boon H, Rochon P, et al. 2006. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 144: 364–367.
16. Gattuso G, Barreca D, Gargiulli C, Leuzzi U, Caristi C. 2007. Flavonoid composition of citrus juices. Molecules 12: 1641–1673.
17. Gielen S, Sandri M, Schuler G, Teupser D. 2009. Risk factor management: 503 antiatherogenic therapies. Eur J Cardiovasc Prev Rehabil 16: S29–36.
18. Gliozzi M, Walker R, Muscoli S, et al. 2013. Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia. Int J Cardiol 170: 140–145.
19. Halcon LL. 2002. Aromatherapy: therapeutic applications of plant essential oils. Minnesota Med 85: 42–46.
20. Hudson JB, Towers GH. 1991. Therapeutic potential of plant photosensitizers. Pharmacol Ther 49: 181–222.
21. Impellizzeri D, Bruschetta G, Di Paola R, et al. 2015. The anti-inflammatory and antioxidant effects of bergamot ice extract (juBJe) in an experimental model of inflammatory bowel disease. Clin Nutr 34(6): 1146–54.
22. Impellizzeri D, Cordaro M, Campolo M, et al. 2016. Anti-inflammatory and antioxidant effects of flavonoid-rich fraction of bergamot juice (BJe) in a mouse model of intestinal ischemia/reperfusion injury. Front Pharmacol 7: 203.
23. Izzo AA, Hoon-Kim S, Radhakrishnan R, Williamson EM. 2016. A critical approach to evaluating clinical efficacy, adverse events and drug interactions of herbal remedies. Phytother Res 30: 691–700.
24. Liberati A, Altman DG, Tetzlaff J, et al. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Br Med J 339: b2700.
25. Liu SH, Lin TH, Chang KM. 2013. The physical effects of aromatherapy in alleviating work-related stress on elementary school teachers in Taiwan. Evid Based Complement Alternat Med. DOI:10.1155/2013/853809.
26. Miceli N, Mondello MR, Monforte MT, et al. 2007. Hypolipidemic effects of Citrus bergamia Risso et Poiteau juice in rats fed a hypercholesterolemic diet. J Agric Food Chem 55: 10671–10677.
27. Miller KD, Rahman ZU, Sledge GW Jr. 2001. Selection bias in clinical trials. Breast Dis 14: 31–40.
28. Mollace V, Ragusa S, Sacco I, et al. 2008. The protective effect of bergamot oil extract on lecitine-like oxyLDL receptor-1 expression in balloon injury-related neointima formation. J Cardiovasc Pharmacol Ther 13: 120–129.
29. Mollace V, Sacco I, Janda E, et al. 2011. Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies. Fitoterapia 82: 309–316.
30. Navarra M, Mannucci C, Delbò M, Calapai G. 2015a. Citrus bergamia essential oil: from basic research to clinical application. Front Pharmacol 6: 36.
31. Navarra M, Ferlazzo N, Cirmi S, et al. 2015b. Effects of bergamot essential oil and its extractive fractions on SH-SY5Y human neuroblastoma cell growth. J Pharm Pharmacol 67(8): 1042–53.
32. Navarra M, Ursino MR, Ferlazzo N, Russo M, Schumacher U, Valentiner U. 2014. Effect of Citrus bergamia juice on human neuroblastoma cells in vitro and in metastatic xenograft models. Fitoterapia 95: 83–92.
33. Ndao DH, Ladas EJ, Cheng B, Sands SA, Snyder KT, Garvin JH Jr. 2012. Inhalation aromatherapy in children and adolescents undergoing stem cell infusion: results of a placebo-controlled double-blind trial. Psychooncology 21: 247–254.
34. Ni CH, Hou WH, Kao CC, et al. 2013. The Anxiolytic Effect of Aromatherapy on Patients Awaiting Ambulatory Surgery: A Randomized Controlled Trial. Evid Based Complement Alternat Med (In press).
35. Ozawa M, Ferenczi K, Kikuchi T, et al. 1999. 312 nm UVB light (narrowband UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 189: 711–718.
36. Pathak MA, Fitzpatrick TB. 1992. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD. J Photochem Photobiol B. 14: 3–22.
37. Pendino GM. 1998. Il bergamotto in terapia medica: attualità e prospettive. Ess Deriv Agr 68: 57–62.
38. Peng SM, Koo M, Yu ZR. 2009. Effects of music and essential oil inhalation on cardiac autonomic balance in healthy individuals. J Altern Complement Med 15: 53–57.
39. Rapisarda A, Germanò MP. 2013. “Citrus bergamia risso and poiteau botanical classification, morphology and anatomy,” in Citrus bergamia: Bergamot and its Derivatives, eds G. Dugo and I. Bonaccorsi (Boka Raton, FL:CRC Press), 9–11.
40. Risitano R, Currò M, Cirmi S, et al. 2014. Flavonoid fraction of Bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-κB inhibition in THP-1 monocytes. PLoS ONE 9e107431.
41. Toth PP, Patti AM, Nikolic D, et al. 2016. Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: a 6 months prospective study. Front Pharmacol 6: 299.
42. Trovato A, Taviano MF, Pergolizzi S, Campolo L, De Pasquale R, Miceli N. 2010. Citrus bergamia risso & poiteau juice protects against renal injury of diet induced hypercholesterolemia in rats. Phytother Res 24: 514–519.
43. Valkova S. 2007. UVB phototherapeutic modalities. Comparison of two treatments for chronic plaque psoriasis. Acta Dermatovenerol Alp Pannonica Adriat 16: 26–30.
44. Visalli G, Ferlazzo N, Cirmi S, et al. 2014. Bergamot juice extract inhibits proliferation by inducing apoptosis in human colon cancer cells. Anticancer Agents Med Chem 14: 1402–1413.
45. Watanabe E, Kuchta K, Kimura M, Rauwald HW, Kamei T, Imanishi J. 2015. Effects of bergamot (Citrus bergamia (Risso) Wright & Arn.) essential oil aromatherapy on mood states, parasympathetic nervous system activity, and salivary cortisol levels in 41 healthy females. Forsch Komplementmed 22: 43–49.
46. Wiebe E. 2000. A randomized trial of aromatherapy to reduce anxiety before abortion. Eff Clin Pract 3: 166–169.
47. Yu J, Wang L, Walzem RL, Miller EG, Pike LM, Patil BS. 2005. Antioxidant activity of citrus limonoids, flavonoids, and coumarins. J Agric Food Chem 53: 2009–2014.